✦ LIBER ✦

EXPRESSION OF BCL-2 PROTEIN IN HYPERPLASTIC POLYPS, ADENOMAS, AND CARCINOMAS OF THE COLON

✍ Scribed by FLOHIL, CLAUDIE C.; JANSSEN, PATRICK A.; BOSMAN, FRED T.

Publisher: John Wiley and Sons
Year: 1996
Tongue: English
Weight: 902 KB
Volume: 178
Category: Article
ISSN: 0022-3417
DOI: 10.1002/(sici)1096-9896(199604)178:4<393::aid-path488>3.0.co;2-g

No coin nor oath required. For personal study only.

✦ Synopsis

The proto-oncogene Bcl-2 encodes a protein that protects cells from programmed cell death (apoptosis). The protein is expressed in the proliferative compartment of several normal tissues, including normal colonic crypts. The aim of this study was to test Bcl-2 expression in colorectal neoplasms, assuming that, as a regulator of apoptosis, it might be involved in the progression from adenoma to carcinoma. To this end, Bcl-2 reactivity was tested by immunohistochemistry in hyperplastic polyps, colonic adenomas, and carcinomas and its expression was compared with staining for the proliferation-associated Ki-67 antigen, using the MIB-1 antibody. Bcl-2 expression occurred in 2 out of 10 hyperplastic polyps and in 31 out of 35 (tubular, villous, and tubulovillous) adenomas, irrespective of their degree of dysplasia. Of ten carcinomas, only three were focally Bcl-2-positive, all moderately to well differentiated. In two of four carcinomas in Bcl-2-positive adenomas, no Bcl-2 staining was observed. High numbers of MIB-1-positive cells were found in all hyperplastic and neoplastic lesions, without apparent correlation between proliferation and Bcl-2 expression. These findings suggest that in the pathogenesis of hyperplastic polyps, increased crypt cell proliferation is primarily involved, but in some lesions decreased apoptosis may play a role. Furthermore, the increased Bcl-2 expression in adenomas but not in the majority of the carcinomas suggests either that decreased apoptosis is not usually involved in the pathogenesis of these lesions or that the regulation of apoptosis in colorectal epithelia involves additional regulatory factors. KEY W 0 R D ~4 k l -2 ; MIB-1; colon; adenoma; carcinoma

📜 SIMILAR VOLUMES

EARLY EXPRESSION OF bcl-2 PROTEIN IN THE

EARLY EXPRESSION OF bcl-2 PROTEIN IN THE ADENOMA-CARCINOMA SEQUENCE OF COLORECTAL NEOPLASIA

✍ KAKLAMANIS, LOUKAS; SAVAGE, ADRIAN; MORTENSEN, NEIL; TSIOTOS, PANAGIOTIS; DOUSSI 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 716 KB

bcl-2 was originally identified as an oncogene involved in follicular lymphomas as a result of chromosomal translocation (14;18). It is now believed that bcl-2 is implicated in the regulation of cell death by inhibiting apoptosis and that its expression is not restricted to haematopoietic cells, but

Over-expression of bcl-xL gene in human

Over-expression of bcl-xL gene in human gastric adenomas and carcinomas

✍ Shinya Kondo; Yasuhisa Shinomura; Shuji Kanayama; Yoshifumi Higashimoto; Jun-Ich 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 French ⚖ 543 KB

The present study was designed to clarify whether bcl-xL is involved in the development of carcinoma in the stomach. Levels of bcl-xL and bcl-2 mRNA were determined by a reverse-transcription/polymerase-chain reaction in endoscopic gastric biopsy specimens from 10 control subjects, 11 patients with

Expression of bcl-2, bax, and bcl-XL pro

Expression of bcl-2, bax, and bcl-XL proteins in azoxymethane-induced rat colonic adenocarcinomas

✍ Yoshinobu Hirose; Naoki Yoshimi; Masumi Suzui; Kunihiro Kawabata; Takuji Tanaka; 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 281 KB 👁 2 views

Using western blotting and immunochemical analysis, we investigated alterations in the expression of the apoptosis-related proteins bcl-2, bax, and bcl-X in colonic adenocarcinomas induced by subcutaneous injection of azoxymethane (AOM) (15 mg/kg body weight weekly for 2 wk) into male Sprague-Dawley

EXPRESSION OF bcl-2 AND p53 INDE NOVO AN

EXPRESSION OF bcl-2 AND p53 INDE NOVO AND EX-ADENOMA COLON CARCINOMA: A COMPARATIVE IMMUNOHISTOCHEMICAL STUDY

✍ MUELLER, JAMES; MUELLER, ELKE; HOEPNER, INGRID; JÜTTING, JUTTA; BETHKE, BIRGIT; 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 910 KB

The development of colorectal carcinoma from adenomas is recognized as the dominant mechanism of colon carcinogenesis. However, early colon carcinomas are being increasingly detected which have no adenomatous elements in their vicinity, and which, despite their small size, already show subrnucosal i

Apoptosis and immunohistochemical bcl-2

Apoptosis and immunohistochemical bcl-2 expression in colorectal adenomas and carcinomas: Aspects of carcinogenesis and prognostic significance

✍ Gustavo Bruno Baretton; Joachim Diebold; Gregor Christoforis; Michael Vogt; Chri 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 982 KB

## BACKGROUND. The Ocl-2 oncoprotein confers a survival advantage to cells by inhibiting programmed cell death (PCD) or apoptosis. Overexpression of bcl-2 probably plays a role in colorectal carcinogenesis. The aims of our study were to determine bcl-2 expression and PCD index in colorectal adenom

bcl-2 expression and prognosis in squamo

bcl-2 expression and prognosis in squamous-cell carcinomas of the esophagus

✍ Mario Sarbia; Fernando Bittinger; Rainer Porschen; Patrick Verreet; Philipp Dutk 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 French ⚖ 587 KB

The bcl-2 proto-oncogene is a known inhibitor of apoptosis and may be an important regulator of tumor growth. In the present study, bcl-2-protein expression was investigated by immunohistochemistry and correlated with prognosis in a series of 150 potentially curatively resected squamous-cell carcino